Breast Cancer

Latest News


Verzenio (abemaciclib) was granted a priority review to a new drug application (NDA) to be used in combination with an aromatase inhibitor for the frontline treatment of women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer, according to Eli Lilly and Company, the manufacturer of the drug.

Chemo brain is one of the many side effects of chemotherapy that can affect us. If you have it, you may not even notice that you have it at first.